News
2hon MSN
Johnson & Johnson’s stock rose 2.4% in premarket trading, enough to pace the Dow Jones Industrial Average’s early gainers.
In the second quarter, J&J’s worldwide oncology sales shot up more than 20 per cent, offsetting declines in sales of its ...
20hon MSN
Merck & Co., Inc. (NYSE:MRK), one of the largest pharmaceutical companies in the world, has lost 15% year-to-date on the ...
Merck, a leading science and technology company, has launched the AAW™ Automated Assay Workstation, a solution powered by ...
GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...
President Trump plans to impose tariffs on pharmaceuticals and semiconductors, impacting companies like Eli Lilly and Apple.
Hong Kong-based Sino Biopharm, which took its stake in LaNova when it participated in the company's $42 million financing ...
HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...
Trump plans steep tariffs on pharmaceuticals and semiconductors by July-end, eyes India trade deal as part of broader ...
Backed by an initial funding of $15 million from the National Science Foundation, the Regenerative Medicine Engine is the ...
CRBN/VHL, Targeted Glue™ degraders for oncology and immunology indications Cambridge, UK, 16 July 2025 - Amphista Therapeutics ('the Company” or 'Amphista”), a leader in the discovery of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results